By: RootSource Media,
Federal cannabis policy is shifting, and like most things in this space, it’s happening in pieces that don’t line up.
The Trump administration has moved forward with the process of shifting marijuana out of Schedule I toward Schedule III, with the DEA still working through hearings and rulemaking. That signals recognition of medical use and could ease the tax burden for state-legal operators under 280E. It’s two steps removed from Schedule I, and it’s still a plant. Plants don’t belong on any schedule. It’s also not legalization or decriminalization, and it doesn’t suddenly make the existing market federally compliant.
At the same time, Trump has been pushing Congress to clean up the hemp language before it takes effect this November, specifically to avoid unintended damage to full-spectrum CBD and other non-intoxicating products. On the surface, both moves point in a positive direction: advancing marijuana policy while trying to preserve hemp. The problem is we still don’t know what the marijuana rescheduling process will ultimately look like or how it will interact with existing state-legal markets. So while one side of the plant is being repositioned at the federal level, the other side of the plant is in panic mode, waiting to see whether the fixes come in time to prevent disruption.
There’s also sloppy language floating around about “FDA-approved marijuana products.” That’s not really a thing in the way people think. What exists are a few pharmaceutical cannabinoid drugs, like Marinol, Syndros, Cesamet, and Epidiolex, that went through the FDA drug approval process. Everything else, from state-legal cannabis to hemp-derived products, sits outside that system. So rescheduling is not an endorsement of what’s currently on shelves. It’s more like an admission that federal policy has been out of sync with reality for a long time.
Looking at Hemp
The ‘Hemp Ban’ language didn’t come through a standalone hemp debate. It was folded into the November 2025 continuing resolution to reopen the government and end the shutdown, with key provisions driven by Mitch McConnell and Andy Harris. Attaching a significant policy shift to a must-pass funding bill left little room for industry input, technical refinement, or a serious look at how a 0.4 milligram per-container THC limit would play out across food, feed, and non-intoxicating products. The result is a rule with wide reach, drafted under deadline pressure, now rippling through parts of the hemp economy it was never clearly designed to address.
So now you have farmers, food producers, and feed operators staring at a rule that was clearly aimed at finished intoxicating cannabinoid products but doesn’t stop there. It bleeds across categories because the definition is too blunt.
That’s where the fractures become obvious.
Some people look at the last few years and see a market that outpaced any real oversight. Others look at the current language and see an overcorrection that risks taking out legitimate hemp products along with the ones regulators are trying to get a handle on. Both views come from real issues. The problem is that the response doesn’t separate them very well.
Congress knows this, which is why multiple bills are now floating around trying to clean it up.
The Farm Bill is also becoming a key vehicle for these fixes. Unlike last-minute funding bills, it offers a more structured opportunity to revisit hemp definitions, THC thresholds, and how different product categories are treated. Much of the real work to sort this out is now shifting into that process.
There are efforts to give states more control over how hemp-derived products are handled within their borders. There are proposals to create an actual federal pathway for CBD instead of leaving it in limbo. Some lawmakers are trying to delay implementation of the new THC limits, so the industry doesn’t get hit all at once. Others are trying to redraw the lines entirely.
That’s a lot of activity for something that should have been clearer the first time.
What’s missing is a fit-for-purpose framework that reflects how hemp and cannabis actually function.
Fiber and grain are not the same as finished consumer products. Hemp foods are not the same as concentrated extracts. Full-spectrum CBD is not the same as products intended for adult use. Lumping all of that together under one metric doesn’t simplify anything. It just creates unintended consequences.
The strange part is watching this happen alongside the marijuana shift. One side of the plant is being pulled into a new federal category, while another side is dealing with rules that don’t reflect how it’s grown, processed, or used.
No one in this space is asking for a free pass (except for some bad actors who have contributed to the noise, and who should literally be weeded out). The ask has been the same for years: clear rules, consistent standards, age-gating where necessary, and something that actually reflects the supply chain from field to finished product.
Rescheduling marijuana doesn’t fix hemp. Tweaking hemp definitions doesn’t fix cannabis. Treating them like separate issues hasn’t worked so far, and it’s not working now.
It’s one plant. The policy hasn’t caught up.
Regulate based on end use and most of these headaches go away. That would be a pretty big win.
